Browsing by 저자 : 도영록
전체 결과 182건 중 1-60 번을 표시중입니다.
-
1
Article A Case of Double-unit Cord Blood Transplantation in Primary Refractory Acute Myeloid Leukemia 김진영 ; 박건욱 ; 도영록 2014
-
2
Article A Case of Floral Variant of Follicular Lymphoma 김진영 ; 도영록 ; 박건욱 ; et al 2011
-
3
Article A Case of Pneumatosis Intestinalis in Ph+ Acute Lymphoblastic Leukemia 김진영 ; 박건욱 ; 송홍석 ; et al 2012
-
4
Article A Combination of Melphalan, Prednisone, and 50 mg Thalidomide Treatment in Non-Transplant-Candidate Patients with Newly Diagnosed Multiple Myeloma 도영록 2011
-
5
Article A Long-Term Survival Case of Primary Angiosarcoma in Liver Treated with Weekly Docetaxel Chemotherapy 김진영 ; 도영록 ; 박건욱 ; et al 2011
- 6 Article A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study 도영록 2023
- 7 Article A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study 도영록 2023
-
8
Article A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer 김진영 ; 도영록 ; 박건욱 ; et al 2010
-
9
Article A Multi-Center, Phase II Clinical T rial of PadexolTM (Paclitaxel) and Cisplatin for Patients Suffering w ith A dvanced Gastric Cancer 도영록 ; 송홍석 ; 박건욱 2005
- 10 Article A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatment 도영록 2022
-
11
Article A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKorea 도영록 2018
-
12
Article A phase II study of biweekly irinotecan and cisplatin for patients with extensive stage disease small cell lung cancer 도영록 ; 송홍석 ; 권기영 2008
- 13 Article A phase II study of biweekly irinotecan plus cisplatin in patients with extensive stage small lung cancer 권기영 ; 도영록 ; 송홍석 ; et al 2008
-
14
Article A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer 송홍석 ; 도영록 2008
-
15
Article A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma 도영록 2020
-
16
Article A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis 도영록 2020
- 17 Article A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial) 도영록 2019
-
18
Article A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome 도영록 2015
-
19
Article A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma 도영록 2017
-
20
Article A retrospective analysis of etiology and outcomes of hemophagocytic lymphohistiocytosis in children and adults 정난이 ; 심예지 ; 김흥식 ; et al 2021
-
21
Article A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score 도영록 2018
-
22
Article Acute promyelocytic leukemia with submicroscopic deletion of 3'-region of PML on derivative chromosome 17 김재룡 ; 김진영 ; 송홍석 ; et al 2008
-
23
Article Adrenalectomy for Metastatic Disease to the Adrenal Gland from Gastric Cancer: Report of a Case 도영록 ; 송홍석 ; 김인호 2007
-
24
Article Adriamycin에 의해 유발된 가역적인 심근병증 1례 도영록 ; 송홍석 ; 조주연 2002
-
25
Article Adult T-cell leukemia/lymphoma with CLL-like morphology 김도훈 ; 하정숙 ; 도영록 2011
-
26
Article Apoptosis of K562 leukemia cells by Abnobaviscum F®, a European mistletoe extract 장병철 ; 도영록 2012
- 27 Article Appropriate Starting Dose of Dasatinib Based on Analyses of Dose-Limiting Toxicities and Molecular Responses in Asian Patients With Chronic Myeloid Leukemia 도영록 2021
-
28
Article Attitudes toward early palliative care in cancer patients and caregivers: a Korean nationwide survey. 도영록 2018
-
29
Article Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study 도영록 2020
-
30
Article Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis 도영록 2018
-
31
Article Bilateral sequential audiovestibular loss as an initial manifestation of chronic myelogenous leukemia 김현아 ; 이현아 ; 이형 ; et al 2014
-
32
Article Biweekly Irinotecan and Cisplatin as Second-line Chemotherapy in Pretreated Patients with Advanced Gastric Cancer: A Multicenter Phase II Study 송홍석 ; 권기영 ; 도영록 ; et al 2005
-
33
Article Bone Marrow and Multiple Extra-Pulmonary Relapses of Pulmonary Marginal Zone B-cell Lymphoma - A Case Report 김진영 ; 도영록 ; 박건욱 ; et al 2010
-
34
Article Bortezomib and the Increased Incidence of Herpes Zoster in Patients with Multiple Myeloma 도영록 2008
-
35
Article Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP) 도영록 2010
-
36
Article Burdens, Needs and Satisfaction of Terminal Cancer Patients and their Caregivers 도영록 2013
- 37 Article Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) 도영록 2023
- 38 Article Busulfan, Melphalan, and Etoposide (Bume) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High Risk Non-Hodgkin's Lymphoma: A Multicenter Randomized Phase II Study by the Consortium for Improving Survival of Lymphoma (CISL) 도영록 2023
- 39 Article Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High-Risk Non-Hodgkin’s Lymphoma: A Multicenter Randomized Phase II Study bythe Consortium for Improving Survival of Lymphoma (CISL) 도영록 2023
-
40
Article c-kit Expression and mutations in peripheral T cell lymphomas, except for extra-nodal NK/T cell lymphomas 도영록 ; 권기영 ; 송홍석 2006
- 41 Article Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial 도영록 2021
-
42
Article Changes in health-related quality of life and quality of care among terminally ill cancer patients and survival prediction: Multicenter prospective cohort study. 도영록 2015
- 43 Article Clinical characteristics and prognostic factors of acquired haemophilia A in Korea 도영록 2021
-
44
Article Clinical Characteristics and Treatment Outcomes in Children, Adolescents, and Young-adults with Hodgkin's Lymphoma: a KPHOG Lymphoma Working-party, Multicenter, Retrospective Study 심예지 ; 김흥식 ; 도영록 2020
- 45 Article Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic era 도영록 2024
-
46
Article Clinical Features and Survival of Patients With Follicular Lymphoma in Korea 도영록 2016
-
47
Article Clinical Features and Survival Outcomes in Patients with Multiple Myeloma: Analysis of Web-Based Data from the Korean Myeloma Registry 도영록 2009
-
48
Article Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone 도영록 2020
-
49
Article Clinical impact of induction treatment modalities and optimal timing of radiotherapy for the treatment of limited-stage NK/T cell lymphoma 도영록 2016
-
50
Article Clinical Outcome and Prognosis of Patients with Primary Sinonasal Tract Diffuse Large B Cell Lymphoma Treated with R-CHOP Chemotherapy; A Study by the Consortium for Improving Survival for Lymphoma 도영록 2015
-
51
Article Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement 김진영 ; 도영록 ; 박건욱 ; et al 2013
-
52
Article Clinical Outcomes and Prognostic Factors of Empirical Antifungal Therapy with Itraconazole in the Patients with Hematological Malignancies: A Prospective Multicenter Observational Study in Korea 도영록 2014
-
53
Article Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas 도영록 ; 권기영 ; 송홍석 2006
- 54 Article Clinical significance of bone marrow involvement by immunoglobulin gene rearrangement in de novo diffuse large B-cell lymphoma: a multicenter retrospective study 도영록 2024
- 55 Article Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial 도영록 2024
-
56
Article Comparison of attitudes towards five end-of-life care interventions (active pain control, withdrawal of futile lifesustaining treatment, passive euthanasia, active euthanasia and physician-assisted suicide): a multicentred cross-sectional survey of Korean patients with cancer, their family caregivers, physicians and the general Korean population 도영록 2018
- 57 Article Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation 도영록 2023
-
58
Article Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant ChronicePhase Chronic Myeloid Leukemia 도영록 2018
- 59 Article Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia 도영록 2021
-
60
Article Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy. 도영록 2017